Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1565, 2006-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA advises caution for recombinant erythropoietins
Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. :
Access to resources
Recommend
Health Canada suspends Adderall, US FDA advises caution
Reactions Weekly, Vol. 1, Iss. 1039, 2005-01 ,pp. :
Health Canada suspends Adderall, US FDA advises caution
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
FDA: new safety information for recombinant erythropoietins
Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. :
US FDA panel advises banning of two asthma drugs
Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. :